Dialysis Initiation and Survival in Patients with Refractory Congestive Heart Failure

Abstract

Background

It has been reported that more than 30% of patients present with congestive heart failure at the initiation of renal replacement therapy (RRT). We followed up a cohort of patients with refractory congestive heart failure (RCHF) who started dialysis between 2005 and 2006 and conducted an observational cohort study in order to evaluate the clinical features at the time RRT was started, and the survival rate of patients with RCHF.

Methods

Data were collected on 33 uremic subjects (24 male) with RCHF, referred by cardiologists, who started dialysis between 2005 and 2006 and were followed-up for 42 months. The following parameters were derived from clinical records: age, sex, history of ischemic heart disease (IHD), cerebro-vascular disease (CVD), peripheral vascular disease (PVD), diabetes, smoking, hypertension, myeloma or malignancies, the cause for dialysis and procedure used to initiate treatment.

Results

RCHF was the cause of initial RRT in 15 patients in 2005 and in 18 the following year, with an incidence of 27 out of 100 patients per year. Diabetes was diagnosed in 51% (n=17) of cases. More than 80% of patients with RCHF had histories of hypertension and smoking. IHD, CVD and PVD were present in 66%, 30% and 54% of cases, respectively. Cancers were recorded in 36% of subjects. Fluid overload was the cause of urgent dialysis in 73% of cases; a central venous catheter (CVC) was placed in 75% of patients. Mean survival of patients with RCHF was 23 months. Eighteen patients died because of cardiovascular events after a mean follow-up of 365±387 days; they had higher prevalence of a smoking history (100% vs. 73%, p=0.02) and CVD (44% vs. 13%, p=0.05) than the survivors.

Conclusions

In uremic patients starting dialysis, RCHF appears to be a frequent condition, comorbidity is high and they require urgent treatment by CVC because of fluid overload. Since RCHF is time- and resource-consuming, nephrologists need to ameliorate its management.

Keywords

Refractory congestive heart failure (RCHF)Dialysis Uremia Survival

Get full access to this article

View all access options for this article.

References

Levey

A.S.

. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start? Am J Kidney Dis 1998; 32(Suppl 3): S5–13.

Fried

L.F.

, Shlipak

M.G.

, Crump

. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364–72.

Banerjee

, Ma

J.Z.

, Collins

A.J.

, Herzog

C.A.

. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol 2007; 2: 1186–90.

Harnett

J.D.

, Foley

R.N.

, Kent

G.M.

, Barre

P.E.

, Murray

, Parfrey

P.S.

. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884–90.

Stack

A.G.

, Molony

D.A.

, Rahman

N.S.

, Dosekun

, Murthy

. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64: 1071–9.

Bongartz

L.G.

, Cramer

M.J.

, Braam

. The cardiorenal connection. Hypertension 2004; 43: e14.

Stack

A.G.

, Bloembergen

W.E.

. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001; 38: 992–1000.